Company / Operating Income per Share
Design Therapeutics, Inc. Operating Income per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.10
FY2025
5-year range
-$1.38 / -$0.52
FY2021-FY2025
Trend
+20.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.52 to $-1.10 over the past 4 years.
Based on SEC 10-K filings.
-1.10 in FY2025.
Declined from $-0.52 to $-1.10 over the past 4 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 20.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.10 | +20.6% |
| FY2024 | -$1.38 | -165.2% |
| FY2021 | -$0.52 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026